Cargando…
Association between Empagliflozin Use and Electrocardiographic Changes
Empagliflozin, a sodium-glucose transporter 2 inhibitor, has been shown to bind to late sodium channels in mice cardiomyocytes. We sought to investigate the electrocardiographic (ECG) features associated with empagliflozin use in patients with diabetes mellitus. We compared ECG features of 101 patie...
Autores principales: | Antwi-Amoabeng, Daniel, Sathappan, Sunil, Beutler, Bryce D., Ulanja, Mark B., Awad, Munadel, Gullapalli, Nageshwara, Duncan, Phillip, Gbadebo, T. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326746/ https://www.ncbi.nlm.nih.gov/pubmed/35892445 http://dx.doi.org/10.3390/clinpract12040059 |
Ejemplares similares
-
Association between electrocardiographic features and mortality in COVID‐19 patients
por: Antwi‐Amoabeng, Daniel, et al.
Publicado: (2021) -
Response of the authors regarding article: “Association between electrocardiographic features and mortality in COVID‐19 patients”
por: Gbadebo, T. David, et al.
Publicado: (2021) -
Sociodemographic Predictors of Outcomes in COVID-19: Examining the Impact of Ethnic Disparities in Northern Nevada
por: Antwi-Amoabeng, Daniel, et al.
Publicado: (2021) -
A nationwide analysis of the outcomes in hospitalized patients with atrial fibrillation and temperature-related illnesses
por: Antwi-Amoabeng, Daniel, et al.
Publicado: (2023) -
Association between histamine 2 receptor antagonists and sepsis outcomes in ICU patients: a retrospective analysis using the MIMI-IV database
por: Firzli, Tarek R., et al.
Publicado: (2023)